iLine Microsystems
Private Company
Total funding raised: $1.2M
Overview
iLine Microsystems is a privately-held, commercial-stage diagnostics company specializing in point-of-care hemostasis monitoring. Its flagship microINR system, launched in 2011, utilizes a proprietary microfluidic Lab-on-a-Chip platform to provide rapid, reliable PT/INR testing for patients on anticoagulants. The company has achieved international expansion, manufacturing millions of test chips annually, and is developing new products like the microDOAC to address the growing market for decentralized coagulation testing and telemedicine. iLine's strategy is centered on providing connected, high-throughput solutions to alleviate pressure on saturated healthcare systems and improve patient quality of life.
Technology Platform
Proprietary microfluidic and Lab-on-a-Chip (LOC) platform integrating sample handling, reagents, mixing, detection, and QC on a disposable plastic chip. Combined with a Machine Vision System (MVS) in meters for optical clot detection and data processing. Enables miniaturized, one-step, connected POCT coagulation assays.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
iLine competes in the POCT coagulation monitoring market against major players like Roche (CoaguChek), Abbott, and Siemens Healthineers, which have broad portfolios and global sales reach. It differentiates through its proprietary microfluidic Lab-on-a-Chip technology, focus on connectivity for telemedicine, and a specific product range targeting both professional and self-testing settings for anticoagulation management.